D.E. Shaw & Co
JBIO

D.E. Shaw & Co’s Jade Biosciences JBIO Stock Holding History

D.E. Shaw & Co’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-493
Closed -$511K – 4477
2024
Q1 		$511K Buy
+493
New +$377K ﹤0.01% 3476
2023
Q2 		– Sell
-456
Closed -$322K – 4224
2023
Q1 		$322K Sell
456
-387
-46% -$321K ﹤0.01% 3730
2022
Q4 		$864K Sell
843
-137
-14% -$99.5K ﹤0.01% 3542
2022
Q3 		$569K Buy
+980
New +$654K ﹤0.01% 3963

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return